WebOur technology is supported by evidence from our population-scale clinical study program, believed to be the largest of its kind. Take me to: 01. Clinical Studies. View. 02. Publications. View. 03. Independent Medical Education. View. 04. ... The Circulating Cell-free Genome Atlas (CCGA) Study. WebThe Circulating Cell-free Genome Atlas Study (CCGA) Official Title: The Circulating Cell-free Genome Atlas Study : Secondary IDs: Study Status. Record Verification: August 2024 : Overall Status: Active, not recruiting: Study Start: August 2016 : Primary Completion: February 11, 2024 [Actual]
History of Changes for Study: NCT02889978 - clinicaltrials.gov
WebThe Circulating Cell-free Genome Atlas Study [email protected] Overview Study type Observational Study IDs About this study GRAIL is using deep sequencing of … WebJun 10, 2024 · A recent clinical trial, the Circulating Cell-free Genome Atlas (CCGA) study, analyzed the genome-wide DNA methylation status to diagnose cancer and identify its tissue of origin (NCT02889978). From an analysis using whole-genome bisulfite sequencing (WGBS) coupled with a targeted sequence, the overall sensitivity was found … react useref object
MCED Resources & Information Galleri® for HCPs
WebJan 13, 2024 · These clinical trials show promising results for the early detection of cancer and confirm cfDNA as a tool for real-time monitoring of acquired therapy resistance, accurate disease-progression... Web† In study participants with cancer. The Circulating Cell-free Genome Atlas (CCGA) Study (NCT02889978) sub-study (CCGA3) included cancer (n=2823) and non-cancer (n=1254) participants. Specificity was 99.5% for noncancer participants. Sensitivity was 51.5% for cancer participants. Cancer Signal Origin WebThe Circulating Cell-free Genome Atlas (CCGA) Study Cleveland Clinic Clinical Trials IRB Study Number 16-1591 Status Suspended Location Cleveland Clinic Main Campus … how to stop a puppy from biting when playing